Min H. Kang
Texas Tech University(US)Bioscience (China)(CN)Texas Tech University Health Sciences Center(US)Xinjiang University(CN)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer therapeutics and mechanisms, Retinoids in leukemia and cellular processes, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research
Most-Cited Works
- → Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy(2009)1,019 cited
- Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.(2002)
- → Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)(2010)230 cited
- → A phase I trial of Depsipeptide (FR901228) in patients with advanced cancer(2002)205 cited
- → DNA-PK as an Emerging Therapeutic Target in Cancer(2019)191 cited
- → Role of OCT4 in cancer stem-like cells and chemotherapy resistance(2019)187 cited
- → Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo